We have changed our visitation policy for the safety of our patients and staff. Click here for the updated visitation policy and click here for information about COVID-19.

[LCID Study Number: 2018-083CIRB]

Lung-MAP: A master protocol to evaluate biomarker-driven therapies and immunotherapies in previously-treated non-small cell lung cancer (lung-MAP screening study)

Targeted Treatment for Advanced Non-Small Cell Lung Cancer

The purpose of this study is to find out if a targeted or immunotherapy treatment will have an effect on specific genes and proteins in your tumor.

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-3071